Table 1.
Characteristics of 12 patients with COVID-19 related AE-ILD.
| Age, years | Sex, | Smoking | Diagnosis of ILD | Comorbidities | 30-day survival | 90-day survival |
|---|---|---|---|---|---|---|
| 73 | Male | Ex | NSIP | HTN, Parkinson | Yes | Yes |
| 85 | Male | Never | IPF | HTN, Hyperlipidemia | Yes | No |
| 83 | Male | Current | CPFE | HTN, IHD | Yes | No |
| 64 | Female | Unknown | CPFE | Cerebral infarction, multiple sclerosis | Yes | Yes |
| 69 | Female | Unknown | IPF | Depression, | No | No |
| 78 | Male | Never | IPF | No | No | No |
| 68 | Male | Current | IPF | DM | No | No |
| 82 | Male | Never | NSIP | Dementia, cerebral infarction, after prostate cancer treatment | No | No |
| 80 | Male | Ex | NSIP | HTN, DM, pleural mesothelioma | Yes | Yes |
| 72 | Male | Current | CPFE | DM, | No | No |
| 73 | Male | Ex | RA-IID | RA | Yes | No |
| 73 | Male | Ex | IPF | HTN | Yes | No |
Abbreviations: ILD, interstitial lung disease; NSIP, nonspecific interstitial pneumonia; IPF, idiopathic pulmonary fibrosis, CPFE, combined pulmonary fibrosis with emphysema; RA-ILD, ILD associated with rheumatoid arthritis; HTN, hypertension; IHD, ischemic heart disease; DM, diabetes mellitus.